Earnings Feed
Start Free
Home/Filings/4/0001415889-12-001461
4//SEC Filing

WILSON JOHN S 4

Accession 0001415889-12-001461

CIK 0001374328other
View on SEC.govCompany Profile

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 11:55 AM ET

Size

14.1 KB

Accession

0001415889-12-001461

Insider Transaction Report

Form 4
Period: 2012-09-17
BOND LABORATORIES, INC.BNLB.OB
WILSON JOHN S
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Purchase

    Series C Convertible Preferred Stock

    2012-09-17+16.7→ 16.7 total
    Exercise: $0.25→ Common Stock (668,000 underlying)
  • Purchase

    Warrant

    2012-09-17+332,500→ 332,500 total
    Exercise: $0.30Exp: 2015-11-15→ Common Stock (332,500 underlying)
Holdings

  • Common Stock

    762,987

  • Common Stock

    962,987

  • Warrants

    Exercise: $0.10From: 2011-06-08Exp: 2021-06-08→ Common Stock (500,000 underlying)
    500,000

  • Common Stock

    166,666

  • Warrants

    Exercise: $0.77From: 2009-12-31Exp: 2014-12-31→ Common Stock (1,487,013 underlying)
    1,487,013

  • Stock Options

    Exercise: $0.09From: 2012-05-09Exp: 2017-04-13→ Common Stock (500,000 underlying)
    500,000
Footnotes (5)
  • [F1]Mr. Wilson acquired 16.7 shares of Series C Convertible Preferred Stock ("Series C Preferred') with a stated value of $10,000 per share, in a private transaction.
  • [F2]The Series C Preferred and Warrants are immediately convertible, or exercisable, as the case may be.
  • [F3]The Series C Preferred are perpetual.
  • [F4]Each share of Series C Preferred converts on a 1-for-40,000 basis.
  • [F5]Mr. Wilson acquired the Series C Preferred and Warrant in a private transaction for aggregate consideration of $40,000.

Documents

1 file

Issuer

BOND LABORATORIES, INC.

CIK 0001374328

→
Entity typeother

Related Parties

1
  • filerCIK 0001497703

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 11:55 AM ET
Size
14.1 KB
View on SEC.gov